Obinutuzumab for previously untreated chronic lymphocytic leukemia

被引：2
|
作者：
不详
机构：
来源：
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2014年 / 12卷 / 04期
关键词：
D O I：
10.12788/jcso.0032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：118 / 120
页数：3
相关论文
共 50 条
  • [31] Fulminant Hemophagocytic Lymphohistiocytosis in a patient with previously untreated Chronic Lymphocytic Leukemia
    Vetter, F.
    Nastasel, V-S.
    Widmer, A.
    Reinehr, M.
    Manz, M. G.
    Zenz, T.
    SWISS MEDICAL WEEKLY, 2019, 149 : 10S - 10S
  • [32] Preliminary Safety and Efficacy Results From a Phase 2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Awan, Farrukh T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 6 - 8
  • [33] Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study
    Al-Sawaf, Othman
    Robrecht, Sandra
    Zhang, Can
    Olivieri, Stefano
    Chang, Naomi
    Fink, Anna
    Tausch, Eugen
    Ritgen, Matthias
    Kreuzer, Karl
    Sivcheva, Lilly
    Niemann, Carsten
    Schwarer, Anthony
    Loscertales, Javier
    Weinkove, Robert
    Strumberg, Dirk
    Kilfoyle, Allanah
    Runkel, Eva
    Eichhorst, Barbara
    Stilgenbauer, Stephan
    Jiang, Yanwen
    Hallek, Michael
    Fischer, Kirsten
    LEUKEMIA & LYMPHOMA, 2023, 64 : S113 - S113
  • [34] Venetoclax-Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia: 5-Year Results of the Randomized CLL14 Study
    Al-Sawaf, Othman
    Zhang, Can
    Robrecht, Sandra
    Kotak, Alex
    Chang, Naomi
    Fink, Anna
    Tausch, Eugen
    Schneider, Christof
    Ritgen, Matthias
    Kreuzer, Karl
    Chyla, Brenda
    Eichhorst, Barbara
    Jiang, Yanwen
    Stilgenbauer, Stephan
    Hallek, Michael
    Fischer, Kirsten
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S274 - S275
  • [35] An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Salvaris, Ross
    Opat, Stephen
    FUTURE ONCOLOGY, 2020, 17 (04) : 371 - 387
  • [36] Elevate Tn Phase 3 Study of Acalabrutinib Plus Obinutuzumab or Acalabrutinib Monotherapy vs Chlorambucil Plus Obinutuzumab (ClbO) in Subjects with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Martens, Uwe
    Sharman, Jeff
    Banerji, Versha
    Fogliatto, Laura Maria
    Herishanus, Yair
    Munir, Talha
    Walewska, Renato
    Follows, George
    Karlsson, Karin
    Ghia, Paolo
    Corbett, Gillian
    Walker, Patricia
    Egyed, Miklos
    Jurczak, Wojciech
    Salles, Gilles
    Janssens, Ann
    Cymbalista, Florence
    Wierda, William
    Coutre, Steven E.
    Pagel, John M.
    Skarbnik, Alan P.
    Kamdar, Manali
    Izumi, Raquel
    Munugala, Veerendra
    Patel, Priti
    Wang, Min Hui
    Wong, Sofia
    Woyach, Jennifer
    Byrd, John
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 127 - 127
  • [37] Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Chen, Christine I.
    Bergsagel, P. Leif
    Paul, Harminder
    Xu, Wei
    Lau, Anthea
    Dave, Nimisha
    Kukreti, Vishal
    Wei, Ellen
    Leung-Hagesteijn, Chungyee
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Johnston, James
    Gibson, Spencer
    Hernandez, Tiffany
    Spaner, David
    Trudel, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1175 - 1181
  • [38] DEVELOPMENT OF A COMPREHENSIVE PROGNOSTIC INDEX FOR PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Pflug, N.
    Bahlo, J.
    Shanafelt, T.
    Eichhorst, B.
    Bergmann, M.
    Elter, T.
    Bauer, K.
    Malchau, G.
    Rabe, K.
    Stilgenbauer, S.
    Doehner, H.
    Jaeger, U.
    Eckart, M.
    Hopfinger, G.
    Busch, R.
    Fink, A.
    Wendtner, C.
    Fischer, K.
    Kay, N.
    Hallek, M.
    HAEMATOLOGICA, 2013, 98 : 32 - 32
  • [39] Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Lampson, Benjamin L.
    Tyekucheva, Svitlana
    Crombie, Jennifer L.
    Kim, Austin I.
    Merryman, Reid W.
    Lowney, Jessica
    Montegaard, Josie
    Patterson, Victoria
    Jacobson, Caron A.
    Jacobsen, Eric D.
    LaCasce, Ann S.
    Arnason, Jon E.
    Armand, Philippe
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2019, 134
  • [40] Leustatin(R) in the treatment of patients with previously untreated chronic lymphocytic leukemia.
    Tallman, MS
    Wollins, E
    Jain, V
    Schiller, G
    Shepherd, J
    Silver, R
    Peterson, L
    BLOOD, 1997, 90 (10) : 2574 - 2574
12345